72.96MMarket Cap-2.59P/E (TTM)
4.5800High4.3326Low18.48KVolume4.3600Open4.4000Pre Close82.14KTurnover0.20%Turnover RatioLossP/E (Static)16.04MShares7.500052wk High-3.40P/B41.49MFloat Cap3.200052wk Low--Dividend TTM9.12MShs Float161.8400Historical High--Div YieldTTM5.62%Amplitude2.5200Historical Low4.4440Avg Price1Lot Size
Owlet inc Stock Forum
Owlet Announces Closing of Public Offering and Comprehensive Debt Refinancing for Total Gross Proceeds of up to $46.6 Million
The Company closed on $11.6 million in proceeds from the underwritten public offering and up to $35 million in proceeds from the debt refinancing.
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced the closing of its underwritten public offering of 3,135,136 shares of the Company's Class A c...
Owlet Announces Proposed Public Offering
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced it intends to offer and sell its Class A common stock in an underwritten public offering. In addition, the Company intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the gross proceeds of its Class A common stock at the public offering price per share, before underwriting discounts and co...
Owlet Announces Expanded Availability of Medically-Certified Dream SockTM Across Europe
Owlet (NYSE:OWLT) announced at Kind + Jugend in Cologne, Germany, that its medically-certified Dream Sock will soon be available in more European countries, including Poland, Greece, and the Czech Republic. The Dream Sock is a CE and UKCA Marked smart digital health infant monitoring device that tracks pulse rate, oxygen saturation, and sleep patterns for babies aged 0-18 months.
The...
Owlet Announces Strong Second Quarter 2024 Results, Achieves Record-Breaking Amazon Prime Day
NEWS
Owlet Announces Strong First Quarter 2024 Results
Owlet, Inc. announced strong first quarter 2024 results with revenue of approximately $14.8 million, up 37% year over year, gross margin at 44.4%, and net income of $3.3 million. The company's adjusted EBITDA loss improved by 46% year over year. Owlet's CEO highlighted the positive feedback on their medical devices and increased demand for their products, projecting continued success in 2024.
Q1 revenue increased by 37% ...
NEWS
Owlet Announces European Medical Certification of Dream SockⓇ
No comment yet